Evidence map›Paper›PMID 36139974›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Do Different Sutures with Triclosan Have Different Antimicrobial Activities? A Pharmacodynamic Approach.

Frederic C Daoud, Fatima M'Zali, Arnaud Zabala, Nicholas Moore, Anne-Marie Rogues

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Frederic C DaoudINSERM, BPH, U1219, Université de Bordeaux, 33000 Bordeaux, France.ORCID 0000-0002-0469-9723
Fatima M'ZaliUMR 5234 CNRS, Laboratoire de Microbiologie Fondamentale et Pathogénicité, Université de Bordeaux, 33000 Bordeaux, France.
Arnaud ZabalaUMR 5234 CNRS, Laboratoire de Microbiologie Fondamentale et Pathogénicité, Université de Bordeaux, 33000 Bordeaux, France.ORCID 0000-0002-1730-6482
Nicholas MooreINSERM, BPH, U1219, Université de Bordeaux, 33000 Bordeaux, France.ORCID 0000-0003-1212-2817
Anne-Marie RoguesINSERM, BPH, U1219, Université de Bordeaux, 33000 Bordeaux, France.
Université de Bordeaux · FRCentre National de la Recherche Scientifique · FR

Funding

Ethicon Limited IIS15-216/2016-11-09
6 · The paper itself

Abstract

(1) Background: Three antimicrobial absorbable sutures have different triclosan (TS) loads, triclosan release kinetics and hydrolysis times. This in vitro study aims to analyse and compare their antimicrobial pharmacodynamics. (2) Methods: Time-kill assays were performed with eight triclosan-susceptible microorganisms common in surgical site infections (SSIs) and a segment of each TS. Microbial concentrations were measured at T0, T4, T8 and T24 h. Similar non-triclosan sutures (NTS) were used as controls. Microbial concentrations were plotted and analysed with panel analysis. They were predicted over time with a double-exponential model and four parameters fitted to each TS × microorganism combination. (3) Results: The microbial concentration was associated with the triclosan presence, timeslot and microorganism. It was not associated with the suture material. All combinations shared a common pattern with an early steep concentration reduction from baseline to 4-8 h, followed by a concentration up to a 24-h plateau in most cases with a mild concentration increase. (4) Conclusions: Microorganisms seem to be predominantly killed by contact or near-contact killing with the suture rather than the triclosan concentration in the culture medium. No significant in vitro antimicrobial pharmacodynamic difference between the three TS is identified. Triclosan can reduce the suture microbial colonisation and SSI risk.

Indexed as

antimicrobialcontact killingpharmacodynamicssurgical site infectionsuturetime-killtranslational modellingtriclosan

Identifiers

PMID36139974
PMCPMC9494962
OpenAlexW4294983422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.